NCT00324649 - Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

September 30, 2008

Conditions

HIV-1

Interventions

DRUG

Truvada

Truvada once daily with continuation of the current NNRTI or PI at randomization.

DRUG

Zidovudine/lamivudine

Continuation of the zidovudine + lamivudine containing regimen plus the current NNRTI or PI at randomization.

Trial Locations (1)

Gilead Sciences, S.L., Madrid